Ninomaru, T., Hata, A., Kokan, C., Okada, H., Tomimatsu, H., & Ishida, J. (2021). Higher osimertinib introduction rate achieved by multiple repeated rebiopsy after acquired resistance to first/second generation EGFR‐TKIs. Thorac Cancer.

Ninomaru, Taira, Akito Hata, Chiyuki Kokan, Hideaki Okada, Hirotaka Tomimatsu, và Jun Ishida. "Higher Osimertinib Introduction Rate Achieved By Multiple Repeated Rebiopsy After Acquired Resistance to First/second Generation EGFR‐TKIs." Thorac Cancer 2021.

Ninomaru, Taira, et al. "Higher Osimertinib Introduction Rate Achieved By Multiple Repeated Rebiopsy After Acquired Resistance to First/second Generation EGFR‐TKIs." Thorac Cancer 2021.